|
US4217344A
(en)
|
1976-06-23 |
1980-08-12 |
L'oreal |
Compositions containing aqueous dispersions of lipid spheres
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4186183A
(en)
|
1978-03-29 |
1980-01-29 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in chemotherapy of leishmaniasis
|
|
US4261975A
(en)
|
1979-09-19 |
1981-04-14 |
Merck & Co., Inc. |
Viral liposome particle
|
|
US4485054A
(en)
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US5049386A
(en)
|
1985-01-07 |
1991-09-17 |
Syntex (U.S.A.) Inc. |
N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4774085A
(en)
|
1985-07-09 |
1988-09-27 |
501 Board of Regents, Univ. of Texas |
Pharmaceutical administration systems containing a mixture of immunomodulators
|
|
US5422251A
(en)
|
1986-11-26 |
1995-06-06 |
Princeton University |
Triple-stranded nucleic acids
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5176996A
(en)
|
1988-12-20 |
1993-01-05 |
Baylor College Of Medicine |
Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
AU7979491A
(en)
|
1990-05-03 |
1991-11-27 |
Vical, Inc. |
Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5420032A
(en)
|
1991-12-23 |
1995-05-30 |
Universitge Laval |
Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
|
|
US5356802A
(en)
|
1992-04-03 |
1994-10-18 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
|
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
|
US5792632A
(en)
|
1992-05-05 |
1998-08-11 |
Institut Pasteur |
Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
CA2181548C
(en)
|
1994-01-18 |
2009-11-03 |
Carlos F. Barbas, Iii |
Zinc finger protein derivatives and methods therefor
|
|
US6242568B1
(en)
|
1994-01-18 |
2001-06-05 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
US5877302A
(en)
|
1994-03-23 |
1999-03-02 |
Case Western Reserve University |
Compacted nucleic acids and their delivery to cells
|
|
US5585245A
(en)
|
1994-04-22 |
1996-12-17 |
California Institute Of Technology |
Ubiquitin-based split protein sensor
|
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
|
AU698152B2
(en)
|
1994-08-20 |
1998-10-22 |
Gendaq Limited |
Improvements in or relating to binding proteins for recognition of DNA
|
|
US6544761B2
(en)
*
|
1994-12-13 |
2003-04-08 |
Human Genome Sciences, Inc. |
Human tissue inhibitor of metalloproteinase-4
|
|
US5789538A
(en)
|
1995-02-03 |
1998-08-04 |
Massachusetts Institute Of Technology |
Zinc finger proteins with high affinity new DNA binding specificities
|
|
US5925523A
(en)
|
1996-08-23 |
1999-07-20 |
President & Fellows Of Harvard College |
Intraction trap assay, reagents and uses thereof
|
|
US6458574B1
(en)
*
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
|
GB2338237B
(en)
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
|
GB9703369D0
(en)
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
|
US6342345B1
(en)
|
1997-04-02 |
2002-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by reporter subunit complementation
|
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
EP2147681A1
(en)
*
|
1997-10-29 |
2010-01-27 |
Genzyme Corporation |
Compositions and methods for treating lysosomal storage disease
|
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
|
DE69942334D1
(de)
|
1998-03-02 |
2010-06-17 |
Massachusetts Inst Technology |
Poly-zinkfinger-proteine mit verbesserten linkern
|
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
WO2001040798A2
(en)
|
1999-12-06 |
2001-06-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
|
WO2001059450A2
(en)
|
2000-02-08 |
2001-08-16 |
Sangamo Biosciences, Inc. |
Cells expressing zinc finger protein for drug discovery
|
|
US20020061512A1
(en)
|
2000-02-18 |
2002-05-23 |
Kim Jin-Soo |
Zinc finger domains and methods of identifying same
|
|
AU2001263155A1
(en)
|
2000-05-16 |
2001-11-26 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
|
US20030073652A1
(en)
*
|
2000-05-17 |
2003-04-17 |
Harvey Pollard |
Ex-vivo and in vivo factor XII gene therapy for hemophilia A and B
|
|
US6852510B2
(en)
|
2000-07-03 |
2005-02-08 |
Gala Design Inc |
Host cells containing multiple integrating vectors
|
|
WO2002007752A2
(en)
|
2000-07-24 |
2002-01-31 |
Gendel Limited |
Red blood cell as vehicle for agent-membrane translocation sequence conjugate
|
|
JP2002060786A
(ja)
|
2000-08-23 |
2002-02-26 |
Kao Corp |
硬質表面用殺菌防汚剤
|
|
GB0024550D0
(enExample)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7419829B2
(en)
|
2000-10-06 |
2008-09-02 |
Oxford Biomedica (Uk) Limited |
Vector system
|
|
DK1325138T3
(da)
|
2000-10-11 |
2013-10-21 |
Shire Human Genetic Therapies |
Optimeret messenger rna
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
GB0108491D0
(en)
|
2001-04-04 |
2001-05-23 |
Gendaq Ltd |
Engineering zinc fingers
|
|
KR100750929B1
(ko)
|
2001-07-10 |
2007-08-22 |
삼성전자주식회사 |
색 보정 기능을 갖는 액정 표시 장치 및 이의 구동 장치및 그 방법
|
|
US20040224385A1
(en)
|
2001-08-20 |
2004-11-11 |
Barbas Carlos F |
Zinc finger binding domains for cnn
|
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
CN100575485C
(zh)
|
2002-01-23 |
2009-12-30 |
犹他大学研究基金会 |
使用锌指核酸酶的定向染色体诱变
|
|
WO2003080809A2
(en)
|
2002-03-21 |
2003-10-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
|
US7074596B2
(en)
|
2002-03-25 |
2006-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse mRNA cap analogues
|
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
|
CA2497913C
(en)
|
2002-09-05 |
2014-06-03 |
California Institute Of Technology |
Use of chimeric nucleases to stimulate gene targeting
|
|
US7446098B2
(en)
*
|
2003-02-18 |
2008-11-04 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiencies
|
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
JP4903689B2
(ja)
|
2004-04-08 |
2012-03-28 |
サンガモ バイオサイエンシズ インコーポレイテッド |
神経障害および神経変性症状を治療するための方法と組成物
|
|
EP1737498A2
(en)
|
2004-04-08 |
2007-01-03 |
Sangamo Biosciences Inc. |
Zinc finger proteins for treatment of neuropathic pain
|
|
AU2005287278B2
(en)
|
2004-09-16 |
2011-08-04 |
Sangamo Biosciences, Inc. |
Compositions and methods for protein production
|
|
US8008468B2
(en)
|
2005-02-16 |
2011-08-30 |
Benitec, Inc. |
RNAi expression constructs with liver-specific enhancer/promoter
|
|
WO2006121866A2
(en)
|
2005-05-05 |
2006-11-16 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences
|
|
CN101273141B
(zh)
|
2005-07-26 |
2013-03-27 |
桑格摩生物科学股份有限公司 |
外源核酸序列的靶向整合和表达
|
|
EP2628794B1
(en)
|
2005-10-18 |
2016-05-04 |
Precision Biosciences |
Rationally designed meganucleases with altered sequence specificity and DNA-binding affinity
|
|
US7935336B2
(en)
*
|
2005-11-18 |
2011-05-03 |
Tokyo Metropolitan Organization For Medical Research |
Highly functional enzyme having α-galactosidase activity
|
|
AU2007267887B2
(en)
|
2006-05-25 |
2013-05-30 |
Sangamo Therapeutics, Inc. |
Variant Foki Cleavage Half-Domains
|
|
WO2007139982A2
(en)
|
2006-05-25 |
2007-12-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene inactivation
|
|
ATE489465T1
(de)
|
2007-04-26 |
2010-12-15 |
Sangamo Biosciences Inc |
Gezielte integration in die ppp1r12c-position
|
|
EP3252161B1
(en)
|
2007-06-06 |
2021-11-17 |
Genzyme Corporation |
Gene therapy for lysosomal storage diseases
|
|
CN104072561B
(zh)
|
2007-06-19 |
2017-12-22 |
路易斯安那州州立大学及农业机械学院管理委员会 |
信使rna帽的抗‑反向硫代磷酸类似物的合成和用途
|
|
US8790345B2
(en)
|
2007-08-21 |
2014-07-29 |
Zimmer, Inc. |
Titanium alloy with oxidized zirconium for a prosthetic implant
|
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
|
SI2946785T1
(sl)
*
|
2008-02-12 |
2019-02-28 |
Amicus Therapeutics, Inc. |
Postopek napovedovanja odziva na farmakološko zdravljenje bolezni s šaperoni
|
|
CA2720903C
(en)
|
2008-04-14 |
2019-01-15 |
Sangamo Biosciences, Inc. |
Linear donor constructs for targeted integration
|
|
DE102008025277A1
(de)
|
2008-05-27 |
2009-12-03 |
Merck Patent Gmbh |
Glaszusammensetzung
|
|
CA2734235C
(en)
|
2008-08-22 |
2019-03-26 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted single-stranded cleavage and targeted integration
|
|
ES2627552T3
(es)
|
2008-12-04 |
2017-07-28 |
Sigma Aldrich Company |
Edición de genoma en ratas usando nucleasas con dedos de cinc
|
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
|
EA022786B1
(ru)
|
2009-07-31 |
2016-03-31 |
Этрис Гмбх |
Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
|
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
|
EP2534173B1
(en)
|
2010-02-08 |
2019-09-11 |
Sangamo Therapeutics, Inc. |
Engineered cleavage half-domains
|
|
AU2011215557B2
(en)
|
2010-02-09 |
2016-03-10 |
Sangamo Therapeutics, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
|
JP5437895B2
(ja)
|
2010-04-20 |
2014-03-12 |
株式会社ジャパンディスプレイ |
表示装置及びその製造方法
|
|
SG185367A1
(en)
|
2010-04-26 |
2012-12-28 |
Sangamo Biosciences Inc |
Genome editing of a rosa locus using zinc-finger nucleases
|
|
SI2566972T1
(sl)
|
2010-05-03 |
2020-04-30 |
Sangamo Therapeutics, Inc. |
Sestavki za povezovanje modulov cinkovega prsta
|
|
KR101953237B1
(ko)
|
2010-05-17 |
2019-02-28 |
상가모 테라퓨틱스, 인코포레이티드 |
신규 dna 결합 단백질 및 이의 용도
|
|
EP2596011B1
(en)
|
2010-07-21 |
2018-10-03 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of a hla locus
|
|
CA3186126A1
(en)
|
2011-09-21 |
2013-03-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of transgene expression
|
|
CA2852955C
(en)
|
2011-10-27 |
2021-02-16 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the hprt locus
|
|
WO2013074999A1
(en)
|
2011-11-16 |
2013-05-23 |
Sangamo Biosciences, Inc. |
Modified dna-binding proteins and uses thereof
|
|
CN113896787A
(zh)
|
2011-12-22 |
2022-01-07 |
弗·哈夫曼-拉罗切有限公司 |
表达载体元件组合、新的生产用细胞产生方法及其在重组产生多肽中的用途
|
|
US20140001721A1
(en)
|
2012-06-28 |
2014-01-02 |
John C. Benko |
Ergonomic cart
|
|
JP6401704B2
(ja)
|
2012-10-10 |
2018-10-10 |
サンガモ セラピューティクス, インコーポレイテッド |
T細胞を修飾する化合物およびその使用
|
|
HK1215873A1
(zh)
|
2012-12-05 |
2016-09-23 |
桑格摩治疗股份有限公司 |
調整代謝紊亂的方法及組合物
|
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
US10604771B2
(en)
|
2013-05-10 |
2020-03-31 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
JP2016521975A
(ja)
|
2013-05-15 |
2016-07-28 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
遺伝的状態の処置のための方法および組成物
|
|
JP6588438B2
(ja)
|
2013-08-28 |
2019-10-09 |
サンガモ セラピューティクス, インコーポレイテッド |
Dna結合ドメインと切断ドメインとを連結するための組成物
|
|
TW202332774A
(zh)
|
2013-10-23 |
2023-08-16 |
美商健臻公司 |
重組醣蛋白及其用途
|
|
CN111330021A
(zh)
*
|
2013-12-09 |
2020-06-26 |
桑格摩生物科学股份有限公司 |
基因组工程化的方法和组合物
|
|
GB201322798D0
(en)
|
2013-12-20 |
2014-02-05 |
Oxford Biomedica Ltd |
Production system
|
|
CN106413760B
(zh)
|
2014-05-08 |
2020-01-14 |
桑格摩生物科学股份有限公司 |
用于治疗亨廷顿病的方法和组合物
|
|
US20170101658A1
(en)
|
2014-07-18 |
2017-04-13 |
Celltheon Corporation |
Methods and compositions for expression of polypeptides in a cell
|
|
US9816074B2
(en)
|
2014-07-25 |
2017-11-14 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
|
|
US9616090B2
(en)
|
2014-07-30 |
2017-04-11 |
Sangamo Biosciences, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
US10179918B2
(en)
|
2015-05-07 |
2019-01-15 |
Sangamo Therapeutics, Inc. |
Methods and compositions for increasing transgene activity
|
|
CN108138159A
(zh)
|
2015-06-23 |
2018-06-08 |
费城儿童医院 |
经修饰的因子ix、以及用于基因转移到细胞、器官和组织的组合物、方法和用途
|
|
PT3368507T
(pt)
|
2015-10-28 |
2023-02-07 |
Acuitas Therapeutics Inc |
Novos lípidos e formulações de nanopartículas lipídicas para distribuição de ácidos nucleicos
|
|
KR20250022906A
(ko)
|
2015-10-28 |
2025-02-17 |
상가모 테라퓨틱스, 인코포레이티드 |
간-특이적 작제물인, 인자 viii 발현 카세트 및 이의 사용 방법
|
|
US10724020B2
(en)
|
2016-02-02 |
2020-07-28 |
Sangamo Therapeutics, Inc. |
Compositions for linking DNA-binding domains and cleavage domains
|
|
ES2901989T3
(es)
|
2016-08-24 |
2022-03-24 |
Sangamo Therapeutics Inc |
Nucleasas específicas de objetivo modificadas
|
|
CA3039673A1
(en)
|
2016-10-20 |
2018-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of fabry disease
|
|
CA3045122A1
(en)
|
2016-12-09 |
2018-06-14 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
US11357834B2
(en)
|
2017-01-10 |
2022-06-14 |
Amicus Therapeutics, Inc. |
Recombinant α-galactosidase A for treatment of Fabry disease
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
KR102735096B1
(ko)
|
2017-10-11 |
2024-11-28 |
(주)셀트리온 |
고발현 및 고기능성 목적 단백질의 생산을 위한 발현 카세트 및 이의 이용
|
|
CN111954540A
(zh)
|
2018-02-08 |
2020-11-17 |
桑格摩生物治疗股份有限公司 |
工程化靶标特异性核酸酶
|
|
JP7577650B2
(ja)
|
2018-10-10 |
2024-11-05 |
アミカス セラピューティックス インコーポレイテッド |
ジスルフィド結合により安定したポリペプチド組成物及びその使用方法
|
|
WO2020142752A1
(en)
*
|
2019-01-04 |
2020-07-09 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of fabry disease
|